BROOKE DAVIDSON: Open Payments
NPI 1477989424 · EVANS MILLS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$234 in 7 payments from 5 companies in 2025. Trend: 2023 $254 · 2024 $121 · 2025 $234
Food & beverage: $234
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $117 |
| PFIZER INC. | 2 | $46 |
| AstraZeneca Pharmaceuticals LP | 1 | $27 |
| GlaxoSmithKline, LLC. | 1 | $25 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $18 |
Products named: Wegovy, FARXIGA, PAXLOVID, TRELEGY ELLIPTA, PREVNAR 20, CAPLYTA, Rybelsus.
Industry payments across NY — which companies pay providers there.
